74
Views
6
CrossRef citations to date
0
Altmetric
Article

Dosimetry and risk from low‐ versus high‐LET radiation of Auger events and the role of nuclide carriers

&
Pages 813-822 | Received 14 Dec 2003, Accepted 05 May 2004, Published online: 03 Jul 2009

References

  • ADELSTEIN, S. J., KASSIS, A. I., BODEI, L. and MARIANI, G., 2003, Radiotoxicity of iodine-125 and other Auger-electron-emitting radionuclides: background to therapy. Cancer Biotherapy and Radiopharmaceuticals, 18, 301–316.
  • BLOOMER, W. D. and ADELSTEIN, S. J., 1977, 5_1251_ iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature, 265, 620–621.
  • BLOOMER, W. D., MCLAUGHLIN, W. H., WEICHSELBAUM, R. R., HANSON, R. N., ADELSTEIN, S. J. and SErrz, D. E., 1981, The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iododeoxyuricline, iodotamoxifen, and iodoantipyrine. Journal Radioanalytical Chemistry, 65, 209–221.
  • BOND, V. P., BENARY, V., SONDHAUS, C. A. and FEINENDEGEN, L. E., 1995, The meaning of linear dose—response relations, made evident by use of absorbed dose to the cell. Health Physics, 68, 786–792.
  • BURKI, H. J., ROOTS, R., FEINENDEGEN, L. E. and BOND, V. P., 1973, Inactivation of mammalian cells after disintegration of 3H or 1251 in cell DNA at —196°C. International Journal of Radiation Biology, 24, 363–375.
  • CARLSON, T. A. and WHITE, R. M., 1963, Formation of fragment ions from CH3Te125 and C2H51125 following the nuclear decays of CH3I125 and C2H5I125. Journal of Chemical Physics, 38, 2930–2934.
  • CHAUDHURY, A., CHARO, J., PARAPURAM, S. K., HUNT, R. C., SELIGER, B. and KIESSLING, R., 2004, Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis in Her2/neu positive tumor cell lines. International Journal of Cancer, 108, 7l–77.
  • Ciro, Y. S., Km, M.-K., CHEADLE, C., NEARY, C., BECKER, K. G. and CHO-CHUNG, Y. S., 2001, Antisense DNAs as multisite genomic modulators identified by DNA microarray. Proceedings of the National Academy of Sciences, USA, 98, 9819–9823.
  • COMMERFORD, S. L., &ND, V. P., CRONKITE, E. P. and REINCKE, U., 1980, Radiotoxicity of intranuclear 1251 atoms not bound to DNA. International Journal of Radiation Biology, 37, 547–554.
  • DATTA, K., DIZDAROGLU, M., JARUGA, P., NEUMANN, R. D. and WINTERS, T. A., 2003, Characterization of a complex 125I-induced DNA double strand break: implications for repair. International Journal of Radiation Biology (in press).
  • DESOMBRE, E. R., SHAFII, B., HANSON, R. N., KUIVANEN, P. C. and HUGHES, A., 1992, Estrogen receptor-directed radio-toxicity with Auger electrons: specificity and mean lethal dose. Cancer Research, 52, 5752–5758.
  • DIEHN, B., HALPERN, A. and STOCKLIN, G., 1976, Specific inactivation of solid carbonic anhydrase upon X-ray resonance absorption in the constituent zinc atom. Journal of the. American Chemical Society, 98, 1077–1079.
  • FEINENDEGEN, L. E., 1975, Biological damage from the Auger effect, possible benefits. Radiation and Environmental Biophysics, 12, 85–99.
  • FEINENDEGEN, L. E., 1991, Radiation risk of tissue late effect, a net consequence of probabilities of various cellular responses. European Journal of Nuclear Medicine, 18, 740–751.
  • FEINENDEGEN, L. E., 2003, Relative implications of protective responses versus damage induction at low-dose and low-dose rate exposures, using the microdose approach. Radiation Protection Dosimetry, 104, 337–346.
  • FEINENDEGEN, L. E., BOND, V. P. and Booz, J., 1994, The quantification of physical events within tissue at low levels of exposure to ionizing radiation. ICRU News, 2, 9–13.
  • FEINENDEGEN, L. E., BOND, V. P. and SONDHAUS, C. A., 2000, The dual response to low-dose irradiation: induction vs. prevention of DNA damage. In T. Yamada, C. Mothersill, B. D. Michael and C. S. Potten (eds), Biological Effects of Low Dose Radiation (Amsterdam: Elsevier), pp. 3–17.
  • FEINENDEGEN, L. E., Booz, J., BOND, V. P. and SONDHAUS, C. A., 1985, Microdosimetric approach to the analysis of cell responses at low dose and low dose rate. Radiation Protection Dosimetry, 13, 299–306.
  • FEINENDEGEN, L. E., HENNEBERG, P. and TISLJAR-LENTULIS, G., 1977, DNA strand breakage and cell repair in human kidney cells after exposure to incorporated iodine-125 and Co-60 g-rays. Current Topics in Radiation Research Quarterly, 12, 436–452.
  • FEINENDEGEN, L. E., POLLYCOVE, M. and SONDHAUS, C. A., 2003, Responses to low doses of ionizing radiation in biological systems. Nonlinearity in Biology—Toxicology—Medicine (in press).
  • HOFER, K. G., 1996, Biophysical aspects of Auger processes. Acta Oncologica, 35, 789–796.
  • HOFER, K. G. and BAO, S. P., 1995, Low-LET and high-LET radiation action of 1251 decays in DNA: effect of cysteamine on micronucleus formation and cell killing. Radiation Research, 141, 183–192.
  • HOFER, K. G., LIN, X. and BAO, S. P., 1996, DNA damage, micronucleus formation and cell death from 1251 decays in DNA. Acta Oncologica, 35, 825–832.
  • INTERNATIONAL COMMISSION ON RADIATION UNIT'S AND MEASUREMENTS, 1983, Microdosimetg. Report 36 (Bethesda: ICRU).
  • INTERNATIONAL COMMISSION ON RADIATION UNIT'S AND MEASUREMENTS, 1998, Fundamental Quantities and Units for Ionizing Radiation. Report 60 (Bethesda: ICRU).
  • INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS, 2002, Absorbed Dose Specification in Nuclear Medicine. Report 67 (Bethesda: ICRU).
  • KARAMYCHEV, V. N., PANYUTIN, I. G., NEUMANN, R. D. and ZHURKIN, V. B., 2000, DNA and RNA folds in transcription complex as evidenced by iodine-125 railioprobing. Journal of Biomolecular and Structural Dynamics, 11, 155–167.
  • KARAMYCHEV, V. N., REED, M. W., NEUMANN, R. D. and PANYUTIN, I. G., 2000, Distribution of DNA strand breaks produced by iodine-123 and indium-111 in synthetic oligonucleotides. Acta Oncologica, 39, 687–692.
  • KARAMYCHEV, V. N., ZITURKIN, V. B., GARGES, S., NEUMANN, R. D. and PANYUTIN, I. G., 1999, Detecting the DNA kinks in a DNA—CRP complex in solution with iodine-125 railioprobing. Nature Structural Biology, 6, 747–750.
  • KAsro, U. and DRITSCHILO, A., 2003, RAF antisense oligonucleotide as a tumor railiosensitizer. Oncogene, 22, 5876–5884.
  • KASSIS, A. I. and ADELSTEIN, S. J., 1980, A rapid and reproducible method for the separation of cells from radioactive media. Journal of Nuclear Medicine, 21, 88–90.
  • KAssis, A. I., FAYAD, F., KmisEY, B. M., SASTRY, K. S. R., TAUBE, R. A. and ADELSTEIN, S. J., 1987, Radiotoxicity of 1251 in mammalian cells. Radiation Research, 111, 305–3128.
  • KRIEG, A. M., Yi, A. K., MATSON, S., WALDSCHMIDT, T. J., BISHOP, G. A., TEASDALE, R., KORETZKY, G. A. and KLINMAN, D. M., 1995, CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546–549.
  • LASTER, B. H., SHAM, G., KAHL, S. B. and WARKENTIEN, L., 1996, The biological effects of Auger electrons compared with cc-particles and Li ions. Acta Oncologica, 35, 917–923.
  • LEE, L. K. and ROTH, C. M., 2003, Antisense technology in molecular and cellular bioengineering. Current Opinion in Biotechnology, 5, 505–511.
  • Li, W., 2002, Iodine-125 Induced DNA Strand Breakage: Contributions of Afferent Physical and Chemical Radiation Action Mechanisms. Report 12/02 (Munich: GSF-National Research Center for Environment and Health).
  • LIBER, H. L., LEMOTTE, P. K. and LrrrLE, B., 1983, Toxicity and mutagenicity of x-rays and [12 I]clUdr or [31-1]TdR incorporated in the DNA of human lymphoblast cells. Mutation Research, 111, 387–404.
  • MARTIN, R. F. and HASELTINE, W. A., 1981, Range of radio-chemical damage to DNA with decay of iodine-125. Science, 213, 896–898.
  • MIYAZAIU, N. and FUJIWARA, Y., 1981, Mutagenic and lethal effects of [5-125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs. Radiation Research, 88, 456–465.
  • MIYAZAKI, N. and SHINOHARA, K., 1993, Cell killing induced by decay of 1251 during the cell cycle: comparison of 125I-antipyrine with 121-bovine serum albumin. Radiation Research, 133, 182–186.
  • Moss, E. G., 2001, RNA interference: it's a small RNA world. Current Biology, 11, R772—R775.
  • NIKJOO, H., PANYUTIN, I. G., TERRISOL, M., VRIGNEAUD, J. M. and LAUGHTON, C. A., 2000, Distribution of strand breaks produced by Auger electrons in decay if 1251 in triplex DNA. Acta Oncologica, 39, 707–712.
  • PAINTER, R. B., YOUNG, B. R. and BURKI, H. J., 1973, Non-repairable strand breaks induced by 1251 incorporated into mammalian DNA. Proceedings of the National Academy of Sciences, USA, 71, 4836–4838.
  • PANYUTIN, I. G., Luu, A. N., PANYIJTIN, I. G. and NEUMANN, R. D., 2001, Strand breaks in whole plasmid DNA produced by the decay of (125)1 in a triplex forming oligonucleotide. Radiation Research, 156, 158–166.
  • PANYUTIN, I. G. and NEUMANN, R. D., 1994, Sequence-specific DNA double-strand breaks induced by triplex forming 1251 labeled oligonucleotides. Nucleic Acids Research, 22, 4979–4982.
  • PANYUTIN, I. G. and NEUMANN, R. D., 1996, Sequence-specific DNA double-strand breaks induced by triplex-directed decay of iodine125. Acta Oncologica, 35, 817–823.
  • PANYUTIN, I. G. and NEUMANN, R. D., 1997, Railioprobing of DNA: distribution of DNA breaks produced by decay of 1251 incorporated into a triplex-forming oligonucleotide correlates with the geometry of the triplex. Nucleic Acids Research, 25, 883–887.
  • PANYUTIN, I. G., WINTERS, T. A., FEINENDEGEN, L. E. and NEUMANN, R. D., 2000, Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Quarterly Journal of Nuclear Medicine, 44, 256–267.
  • PANYUTIN, I. G., WINTERS, T. A., FEINENDEGEN, L. E. and NEUMANN, R. D., 2003, Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. In L. E. Feinendegen, W. W. Shreeve, W. C. Eckelman, Y.-W. Bahk and H. N. Wagner (eds), Molecular Nuclear Medicine: The Challenge of Genomics and Protomics to Clinical Practice (Berlin: Springer), pp. 697–712.
  • PASTWA, E., NEUMANN, R. D., MEZIIEVAYA, K. and WINTERS, T. A., 2003, Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiation Research, 159, 251–261.
  • POMPLUN, E., 2000, Auger electron spectra. Acta Oncologica, 39, 673–579.
  • POMPLUN, E., Booz, J. and CHARLTON, D. E., 1987, A Monte-Carlo simulation of Auger cascades. Radiation Research, 111, 533–552.
  • ROBSON, T., PRICE, M. E., MOORE, M. L., JOINER, M. C., MCKELVEY-MARTIN, V. J., McKEowN, S. R. and HIRST, D. G., 2000, Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced railioresistance. International Journal of Radiation Biology, 76, 617–623.
  • Rossi, H. H., 1967, Energy distribution in the absorption of radiation. Advances in Biological and Medical Physics, 11, 27–85.
  • Rossi, H. H. and KELLERER, A. M., 1972, Radiation carcinogenesis at low doses. Science, 78, 200–202. SASTRY, K. S. R., HOWEIT, R. W., RAO, D. V., MYLAVARAPU, V. B.,
  • KAssis, A. I., ADELSTEIN, S. J., WRIGHT, H. S. A., HAMM, R. N. and TURNER, J. K, 1988, Dosimetry of Auger emitters: physical and phenomenological approaches. In K. F. Baverstock and D. K Charlton (eds), DNA Damage by Auger Emitters (London: Taylor & Francis), pp. 27–38.
  • SEDELNIKOVA, 0. A., PANYUTIN, I. G., THIERRY, A. R. and NEUMANN, R. D., 1998, Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. Journal of Nuclear Medicine, 39, 1412–1418.
  • SEDELNIKOVA, 0. A., ROGAKU, E. P., PANYUTIN, I. G. and BONNER, W. M., 2002, Quantitative detection of (125)IdU-induced DNA double strand breaks with gamma-H2AX antibody. Radiation Research, 158, 486–492.
  • SHINOHARA, K., NAKANO, H. and O'HARA, H., 1996, Detection of Auger enhancement induced in HeLa cells labeled with iododeoxyuricline and irradiated with 150 kV x-rayseffects of cysteamine and climethylsulfoxide. Acta Oncologica, 35, 869–875.
  • SUN, J. S. and HELENE, C., 2003, Oligonucleotides and derivatives as gene-specific control agents. Nucleosides Nucleotides and Nucleic Acids, 5–8, 489–505.
  • Tusam, T., 2001, RNA interference and small interfering RNAs. Chembiochemistry, 4, 239–245.
  • XUE, L. Y., BUTLER, N. J., MAKRIGIORGOS, G. M., ADELSTEIN, S. J. and KAssis, A. I., 2002, Bystander effect produced by radiolabeled tumor cells in vivo. Proceedings of the National Academy of Sciences, USA, 99, 13765–13770.
  • ZAMECNIK, P. C. and STEPHENSON, M. L., 1978, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences, USA, 75, 280–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.